2 Credits (12 modules) - $40 All other participants Certificate of Completion (12 modules) - $40

To receive credit participants must:

• Complete a minimum of 12 modules, excluding the introduction
• Complete the post-tests with an aggregate score of 70%
• Complete the online evaluation, registration and payment process (see link below)

CREDIT DESIGNATION
The University of Miami Leonard M. Miller School of Medicine designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.

OBJECTIVES
At the conclusion of this activity participants are able to:

• Incorporate the federal regulations and policies, which protect human subjects into the research environment.
• Improve human subjects research study design through greater attention to potential risks and harms associated with human subject participation in research.
• Evaluate the Belmont Report as the foundation of US policies toward human subjects research.
• Identify how risks and potential harms associated with participation in social and behavioral human subjects research are less predictable with respect to occurrence, effect and long term outcome.

CITI Good Clinical Practices Course
CREDIT DESIGNATION PERIOD - July 9, 2010 - June 30, 2013
DATE OF ORIGINAL RELEASE - April 2007
DATE OF MOST RECENT UPDATE - June 2010

Continuing Education Certificate Fee
Physician (AMA PRA Category 1 Credit™) 4 Credits (8 modules) - $60 All other participants Certificate of Completion (8 modules) - $60

To receive credit participants must:

• Complete a minimum of 8 modules, excluding the introduction
• Complete the post-tests with an aggregate score of 70%
• Complete the online evaluation, registration and payment process (see link below)

CREDIT DESIGNATION
The University of Miami Leonard M. Miller School of Medicine designates this educational activity for a maximum of 4 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.

OBJECTIVES
At the conclusion of this activity participants are able to:

• Incorporate the federal regulations for drug development into clinical research.
• Determine the role of the International Conference on Harmonisation as it relates to clinical research.
• Develop studies that are aligned with the international standards for clinical research.
• Identify clinical researcher responsibilities.

CITI Health Information Privacy and Security Course
CREDIT DESIGNATION PERIOD: July 23, 2010 - June 30, 2013
DATE OF ORIGINAL RELEASE - July 2010
DATE OF MOST RECENT UPDATE - May 2010

Continuing Education Certificate Fee
Physician (AMA PRA Category 1 Credit™) 1.5 Credits (5 modules) - $10 Psychologist (CE Credit) 1.5 Credits (5 modules) - $10 All other participants Certificate of Completion (5 modules) - $10

To receive credit participants must:

• Complete a minimum of 5 modules as follows:

  1. Privacy Rules: Introduction to Federal and State Requirements

  2. Security Rules: Basics of Being Secure, Part 1

  3. Security Rules: Basics of Being Secure, Part 2

  4. Security Rules: Introduction to Federal and State Requirements

  AND

  5. ONE of the following modules: Privacy Rules: Clinicians Privacy Rules: Researchers Privacy Rules: Students and Instructors Privacy Rules: Fundraisers Privacy Rules: Marketers

• Complete the post-tests with an aggregate score of 70%
• Complete the online evaluation, registration and payment process (see link below)

CREDIT DESIGNATION
The University of Miami Leonard M. Miller School of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.

OBJECTIVES
At the conclusion of this activity participants are able to:

• Use protected identifiable health information only for legitimate work purposes
• Utilize minimum necessary information for intended work purposes
• Employ additional protections for designated sensitive types of health information
• Provide appropriate, timely and accurate information to designated organizational representatives about privacy problems that are observed or suspected
• Provide appropriate, timely and accurate information to patients about their privacy rights
• Incorporate information security practices into the context of daily professional activities (viz., when accessing, storing or disclosing identifiable health information in the systems used in their practice settings), in order to secure patients' privacy rights.

SUMMARY OF FACULTY DISCLOSURE
The following authors and planners have indicated that they have no relevant financial relationships with commercial interests:

Tracy Arwood, MS	Elizabeth Bankert, MA	Paul Braunschweiger, PhD	Anita Cava, JD
Gary L. Chadwick, PharmD, MPH	Maristela Cho, MA	Jeffrey M. Cohen, PhD, CIP	Jeffrey Cooper, MD, MMM
Reid Cushman, PhD	Deborah Dickstein, MPH	Norma Epley, MS	Janelle Erickson, MPH
E. Dawn Fitzgibbons, PhD	Robin Fiore, PhD	David Forster, JD, MA, CIP	Barbara Davis Goldman, PhD
Kenneth Goodman, PhD	Bruce Gordon, MD	Alison Handler, BSN, CCRC	Karen Hansen
Lorna Hicks, MS, CIP	Stephan Kiefer, PhD, CIP	Susan Kortensky, MPH	Wenjin Li, MD
Erica Lim, MSW	Judy Matuk, MS	Helen McGough, MA	David Miller, PhD
Gordon Olacsi, CIP	Diane Paul, MS, RN	Sangeeta Panicker, PhD	Charles E. Pietri, BA
Joan Porter, DPA, MPH	Ernest Prentice, PhD	Susan L. Rose, PhD	Deborah Rosenbaum, CRCC, CCRA, CCRT
Lawrence B. Rosenfeld, PhD	Cheryl Savini, CIP	Ada Sue Selwitz, MA	Mary Simmerling, MA
Karen Smith, PhD	Celia Walker, MA	Barbara Young, PhD